Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jan Kolčava"'
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-6 (2022)
Abstract Background Serum antibodies to myelin-oligodendrocyte glycoprotein (MOG) are biomarkers of MOG-IgG-associated disorder (MOGAD), a demyelinating disease distinct from both multiple sclerosis and aquaporin-4-IgG neuromyelitis optica spectrum d
Externí odkaz:
https://doaj.org/article/3baf940403814884a824c417483dfbe7
Autor:
Jan Kocica, Jan Kolcava, Michaela Sladeckova, Pavel Stourac, Eva Vlckova, Filip Dosbaba, Jitka Kratochvilova, Josef Bednarik
Publikováno v:
Journal of Rehabilitation Medicine, Vol 54 (2022)
Objective: Long-term physiotherapy is of considerable benefit to patients with multiple sclerosis (MS) who have motor dysfunction or gait impairment. The aim of this study was to determine the effectiveness of a 12-week intensive circuit class therap
Externí odkaz:
https://doaj.org/article/734c9063b3ab4e7b91753be545aeee13
Autor:
Martina Petrášová, Iva Šrotová, Jan Kolčava, Pavel Štourač, Ludmila Hynková, Miloš Keřkovský, Hana Pikulová, Eduard Neuman, Leoš Kren, Eva Vlčková
Publikováno v:
Frontiers in Neurology, Vol 14 (2024)
Cerebral tumors and multiple sclerosis (MS) can show overlapping clinical and magnetic resonance imaging (MRI) features and even occur concurrently. Due to the emergence of new symptoms, not usually MS related, an MRI was conducted in a 29-year-old w
Externí odkaz:
https://doaj.org/article/9e416ada4f694edb9a06f6775312369c
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Tumefactive demyelinating lesions belong to the rare variants of multiple sclerosis, posing a diagnostic challenge since it is difficult to distinguish them from a neoplasm or other brain lesions and they require a careful differential diagnosis. Thi
Externí odkaz:
https://doaj.org/article/9bc322f42ca14d7dbdbc67b4c912aca4
Publikováno v:
Multiple Sclerosis and Related Disorders. 71:104566
Publikováno v:
Česká a slovenská neurologie a neurochirurgie. :285-290
Publikováno v:
Česká a slovenská neurologie a neurochirurgie.
Publikováno v:
Česká a slovenská neurologie a neurochirurgie.
Publikováno v:
Neurological Sciences.
Natalizumab is an effective therapy in the treatment of relapsing-remitting multiple sclerosis; it induces lymphocytosis (NIL, natalizumab-induced lymphocytosis) and changes the peripheral lymphocyte pattern. This study aims to evaluate NIL, peripher
Autor:
Jan Vollert, Josef Bednarik, J. Jarkovsky, Ladislav Dušek, Eva Vlčková, Jan Kolčava, Iva Šrotová, Jan Kočica, Monika Hulová
Publikováno v:
European journal of pain (London, England)REFERENCES. 25(3)
Background Central neuropathic extremity pain (CNEP) is the most frequent type of pain in multiple sclerosis (MS). The aim of the present study was to evaluate sensory and pain modulation profiles in MS patients with CNEP. Methods In a single-centre